Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410305 · ClinicalTrials.gov registry record
Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 290
- Enrollment target
NCT01410305: Completed study, sponsored by University Hospitals Cleveland Medical Center.
NCT01410305 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01410305 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
The relationship of Vitamin D levels in children and young adults to atherosclerosis.
Primary Outcome
To perform a cross-sectional analysis of blood vitamin D status among the HIV-infected children and young adults to evaluated the point prevalence fo plasma 25(OH)D levels indicating vitamin D insufficiency, deficiency and severe deficiency, and to compare the prevalence to a matched uninfected healthy control group.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-12 |
What the finished NCT01410305 record still lists
NCT01410305 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01410305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01410305 about?
NCT01410305 is a clinical study titled "Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults". The relationship of Vitamin D levels in children and young adults to atherosclerosis.
What is the current status of trial NCT01410305?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2011-09. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01410305?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia